Company profile: Fertin Pharma
1.1 - Company Overview
Company description
- Provider of innovative, high-quality pharmaceutical and nutraceutical chewing gum products, partnering with leading global pharma companies as a preferred B2B partner for nicotine chewing gum. Offers Zapliq liquefying tablets, compressed and extruded gums (for nicotine replacement therapy and other applications), lozenges, pouch powder, and custom co-developed delivery systems with controlled release.
Products and services
- Extruded Gum: Dual-form (coated or uncoated) chewing gum constructed for nicotine replacement therapy and other applications, available in coated and uncoated variants to match product requirements
- Compressed Gum: Multi-layered, controlled-release chewing gum architected to manage release of active ingredients, suitable for moisture- or heat-sensitive components in structured layers
- Zapliq®: Patented tablet that liquefies when chewed, delivering fast oral administration with complete release of active ingredients, suitable for sensitive ingredients
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Fertin Pharma
Nutriband
HQ: United States
Website
- Description: Provider of abuse-deterrent transdermal technologies and drug delivery systems, including the AVERSA platform integrating abuse-deterrent features into patches for fentanyl, buprenorphine, and methylphenidate, and 4P transdermal systems delivering Exenatide for Type 2 Diabetes and FSH for infertility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutriband company profile →
Hallux
HQ: United States
Website
- Description: Provider of a physician-applied topical terbinafine gel for treating onychomycosis. Hallux Subungual Gel (HSG) is applied directly onto the nail bed, utilizing the subungual space for targeted delivery to the infection site.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hallux company profile →
Biora Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology as a biotech company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biora Therapeutics company profile →
Bionaut Labs
HQ: United States
Website
- Description: Provider of microscale robotic technology for precise delivery of therapies to targeted CNS disease areas; a platform for biologics and small molecules; diagnostic fluid and tissue sampling; long-term in vivo sensing and monitoring; localized electrical stimulation or dampening; and minimally invasive hydrocephalus treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bionaut Labs company profile →
NTT
HQ: United States
Website
- Description: Provider of practical drug delivery systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NTT company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Fertin Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Fertin Pharma
2.2 - Growth funds investing in similar companies to Fertin Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Fertin Pharma
4.2 - Public trading comparable groups for Fertin Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →